Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Abroad (travel likely)RecruitingPHASE3
Conditions
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Octapharma Research Site, Birmingham, Alabama, United States
Octapharma Research Site, Orange, California, United States
Octapharma Research Site, Louisville, Kentucky, United States
Octapharma Research Site, Philadelphia, Pennsylvania, United States
Octapharma Research Site, Houston, Texas, United States
Octapharma Research Site, Charlottesville, Virginia, United States